The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies
- PMID: 30251730
- PMCID: PMC6201010
- DOI: 10.15537/smj.2018.9.22824
The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies
Abstract
Objectives: To determine effective risk factors on mortality in febrile neutropenic cases with hematologic malignancy. Patients with hematologic diseases are more prone to infections and those are frequent causes of mortality.
Methods: This retrospective study was performed using data of 164 febrile neutropenic cases with hematologic malignancies who were followed up in a hematology clinic of a tertiary health care center between 2011-2015. The relationship between descriptive and clinical parameters rates and rates of mortality on the 7th and the 21st days were investigated.
Results: Patients with absolute neutrophil count less than 100/mm3, duration of neutropenia longer than 7 days, pneumonia or gastrointestinal foci of infection, central catheterization (p=0.025), isolation of Gram (-) bacteria in culture, carbapenem resistance, septic shock, and bacterial growth during intravenous administration of antibiotic treatment were under more risk for mortality on both the 7th and the 21st days. The final multivariate logistic regression results showed that pneumonia (p less than 0.0001), septic shock (p=0.004) and isolation of Gram-negative bacteria (p=0.032) were statistically significant risk factors.
Conclusion: Early diagnosis and appropriate treatment of serious infections, which are important causes of morbidity and mortality, are crucial in patients with febrile neutropenia. Thus, each center should closely follow up causes of infection and establish their empirical antibiotherapy protocols to accomplish better results in the management of febrile neutropenia.
Similar articles
-
Shock and Early Death in Hematologic Patients with Febrile Neutropenia.Antimicrob Agents Chemother. 2019 Oct 22;63(11):e01250-19. doi: 10.1128/AAC.01250-19. Print 2019 Nov. Antimicrob Agents Chemother. 2019. PMID: 31405857 Free PMC article. Review.
-
Association between inappropriate empirical antimicrobial therapy and mortality in gram-negative bloodstream infections in patients with febrile neutropenia and hematological malignancy.J Infect Chemother. 2025 Feb;31(2):102538. doi: 10.1016/j.jiac.2024.10.006. Epub 2024 Oct 11. J Infect Chemother. 2025. PMID: 39396607
-
Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.Turk J Haematol. 2015 Sep;32(3):243-50. doi: 10.4274/tjh.2013.0422. Turk J Haematol. 2015. PMID: 25913035 Free PMC article.
-
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.PLoS One. 2013;8(1):e54190. doi: 10.1371/journal.pone.0054190. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23372683 Free PMC article. Clinical Trial.
-
[Febrile neutropenia in onco-hematology patients hospitalized in Intensive Care Unit].Bull Cancer. 2015 Apr;102(4):349-59. doi: 10.1016/j.bulcan.2014.11.003. Epub 2015 Mar 20. Bull Cancer. 2015. PMID: 25799163 Review. French.
Cited by
-
Clinical factors predictive of mortality in acute leukemia patients with febrile neutropenia.Am J Blood Res. 2021 Feb 15;11(1):59-65. eCollection 2021. Am J Blood Res. 2021. PMID: 33796390 Free PMC article.
-
Clinical factors predictive of recurrent febrile neutropenia in adult patients with acute leukemia.Leuk Res Rep. 2022 Feb 15;17:100296. doi: 10.1016/j.lrr.2022.100296. eCollection 2022. Leuk Res Rep. 2022. PMID: 35251930 Free PMC article.
-
Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models.BMC Infect Dis. 2023 Apr 18;23(1):247. doi: 10.1186/s12879-023-08182-3. BMC Infect Dis. 2023. PMID: 37072711 Free PMC article.
-
Diagnostic value of procalcitonin in infections in patients with malignant hematologic diseases.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 May 28;49(5):721-729. doi: 10.11817/j.issn.1672-7347.2024.230589. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39174886 Free PMC article. Chinese, English.
-
Shock and Early Death in Hematologic Patients with Febrile Neutropenia.Antimicrob Agents Chemother. 2019 Oct 22;63(11):e01250-19. doi: 10.1128/AAC.01250-19. Print 2019 Nov. Antimicrob Agents Chemother. 2019. PMID: 31405857 Free PMC article. Review.
References
-
- Tohamy ST, Aboshanab KM, El-Mahallawy HA, El-Ansary MR, Afifi SS. Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations. Infect Drug Resist. 2018;11:791–803. - PMC - PubMed
-
- Forcina A, Lorentino F, Marasco V, Oltolini C, Marcatti M, Greco R, et al. Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018;24:1476–1482. - PubMed
-
- Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730–751. - PubMed
-
- Infectious Diseases Society of Taiwan; Hematology Society of Taiwan; Medical Foundation in Memory Dr. Deh-Lin Cheng; Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education;CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccine. Guidelines for the use of antimicrobial agents in patients with febrile neutropenia in Taiwan. J Microbiol Immunol Infect. 2005;38:455–457. - PubMed
-
- Akova M, Paesmans M, Calandra T, Viscoli C. International Antimicrobial Therapy Group of the European Organization for Research and Treatment of Cancer. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer. Clin Infect Dis. 2005;40:239–245. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources